Drebrin is a filament-binding protein involved in organizing the dendritic pool of actin. Previous in vivo studies identified the actin-binding domain of drebrin (DrABD), which causes the same rearrangements in the cytoskeleton as the full-length protein. Site-directed mutagenesis, electron microscopic reconstruction, and chemical cross-linking combined with mass spectrometry analysis were employed here to map the DrABD binding interface on actin filaments. DrABD could be simultaneously attached to two adjacent actin protomers using the combination of 2-iminothiolane (Traut's reagent) and MTS1 [1,1-methanediyl bis(methanethiosulfonate)]. Site-directed mutagenesis combined with chemical cross-linking revealed that residue 238 of DrABD is located within 5.4 Å from C374 of actin protomer 1 and that native cysteine 308 of drebrin is near C374 of actin protomer 2. Mass spectrometry analysis revealed that a zero-length crosslinker, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, can link the N-terminal G-S extension of the recombinant DrABD to E99 and/or E100 on actin. Efficient cross-linking of drebrin residues 238, 248, 252, 270, and 271 to actin residue 51 was achieved with reagents of different lengths (5.4-19 Å). These results suggest that the "core" DrABD is centered on actin subdomain 2 and may adopt a folded conformation upon binding to F-actin. The results of electron microscopic reconstruction, which are in a good agreement with the cross-linking data, revealed polymorphism in DrABD binding to F-actin and suggested the existence of two binding sites. These results provide new structural insight into the previously observed competition between drebrin and several other F-actin-binding proteins. 
Introduction
Dendritic spines are known to be very motile and change their shape during neuronal development and in adult brain in response to various stimuli. 1 The actin cytoskeleton is a primary modulator of spine morphology. Drebrin is a filament-binding protein that is involved in organizing the dendritic pool of actin. 1 It was shown that synaptic deterioration in the brains of Alzheimer's disease patients is accompanied by dramatically decreased levels of drebrin. Reduced drebrin levels are also observed in Down syndrome. 2 Biochemical analysis of various tissues revealed that depending on specific growth state and cell density, drebrin can form higher-order oligomers named "drebrosomes," which consist of drebrin and actin alone. 3, 4 It was hypothesized that such complexes allow for high local concentrations of drebrin and may play a role in the local regulation of actin assembly, as was previously shown for some tropomyosins. 5 Drebrin binds to F-actin with a stoichiometry of one to five protomers (K d of ∼ 0.12 μM) and shows no actin severing, nucleating, or bundling activity in vitro. 6 It was previously reported that drebrins compete with F-actin-binding proteins, such as α-actinin, tropomyosin, and fascin. [6] [7] [8] Drebrin inhibits the actin-activated ATPase activity of myosin, but its effect on actomyosin sliding velocity remains unclear. A 3-fold decrease in actin sliding velocity was previously reported, but it was not confirmed in recent studies. 9, 10 According to in vitro studies, drebrin can be displaced from actin filaments by cofilin. 11 This observation is consistent with the finding that drebrin loss is accompanied by increased levels of cofilin in the brains of Alzheimer's disease patients. 2 Drebrin shares homology with mammalian actinbinding protein 1 (mAbp1) through an N-terminal ADF-homology domain and helical/charged motif (HCm), which is specific only to these two proteins. 12, 13 However, the helical/charged motif is more extended in drebrins than in mAbp1 and contains a unique sequence (residues 233-300/317) that was identified in previous in vivo studies as the actin-binding domain of drebrin (DrABD) (Scheme 1). 14, 15 Interestingly, this 85-amino-acid DrABD causes the same rearrangements in the actin cytoskeleton as the full-length drebrin and is highly conserved among mammals. 8, 14 Both drebrin and the homologous mAbp1 are present in neuronal cells and contain an ABD within their helical/ charged motif. 1, 16 Nevertheless, overexpression of DrABD and the helical/charged domain of mAbp1 has different effects on the morphology and density of dendritic spines. Similar to full-length drebrin, overexpression of DrABD in rat hippocampal neurons transforms mature dendritic spine into immature dendritic filopodia (without changing the overall density of the spines) and causes the loss of synaptic contacts. This destabilizing effect of drebrin on spine morphology appears to be mediated entirely through its ABD. 8 Thus, DrABD structurally and functionally represents a unique motif among the known actin-binding modules.
The important role of drebrin in actin regulation calls for structural understanding of the actindrebrin complex. To date, no structural information on drebrin-actin interaction has been reported. In this study, we probed the binding interface of DrABD on actin filaments using site-directed mutagenesis, electron microscopic (EM) reconstruction, and chemical cross-linking combined with mass spectrometry (MS) analysis. Our results revealed that DrABD makes extensive contacts with subdomain 1 (SD1) and SD2 on actin and shows polymorphism in F-actin binding. Our data provide structural insight into the previously observed competition between drebrin and some of the actin side-binding proteins, such as α-actinin, cofilin, and tropomyosin.
Results

Characterization of the drebrin constructs
It was previously documented that only the N-terminal part of the drebrin molecule and DrABD in particular show actin binding and remodeling activity in vivo. We compared the actin binding properties of the isolated drebrin ADFhomology domain (drADF; residues 1-134), DrABD, and drebrin construct 1-300 containing both ADF and DrABD domains. Since it was previously shown that overexpression of both the 233-317 drebrin fragment (DrABD) and the 233-300 drebrin fragment (DrABD 300 ) causes in vivo effects similar to those of the full-length drebrin, 14,15 the actin binding properties of these constructs were tested under identical experimental conditions and compared with each other.
Drebrin 1-300 binds to F-actin with high affinity, K d of ∼ 0.2 μM (similar to that of full-sized drebrin), 6 and a binding stoichiometry of ∼1:3 (Fig. 1a) . Under the conditions of our experiments, the isolated drADF did not show any binding to F-actin ( Fig. 1c and d) .
Pelleting experiments have shown that N-GST (glutathione S-transferase)-fused DrABD binds to Factin with relatively low affinity compared with the construct 1-300 (K d = 6.6 ± 0.4 μM) (Fig. 1b) . The Cterminal truncation of DrABD, to produce DrABD 300 , does not affect its binding to F-actin significantly (K d = 7.6 ± 0.6 μM). For both constructs, the DrABD/F-actin binding stoichiometry was close to 1:2 DrABD/actin protomers; the actual mole ratio (1:1.6) may reflect DrABD oligomerization, partial DrABD has no homology among known proteins, and its sequence is abundant in glutamic acid (∼ 19%) and arginine (∼11%) (Fig. 2a) . The secondary structure of this actin-binding module, as revealed by circular dichroism (CD) spectroscopy, contains 28% helix, 15% β-sheet, 21% turns, and 36% random coil (a total of 57% unstructured) (Fig. 2b) . The secondary structure of DrABD is invariable over the pH range 5.0-8.6 (data not shown).
EM reconstruction of F-actin decorated with the drebrin constructs EM images of F-actin alone and actin decorated with DrABD and 1-300 constructs are shown in Fig. 3a , b, and b ⁎ , respectively. Despite affinity differences, the same modes of F-actin binding and binding polymorphism were documented for both DrABD (Fig. 3d-h ) and drebrin 1-300 constructs (Fig. 3d ⁎ -h ⁎ ) .
Extensive decoration of actin filaments was observed in the presence of DrABD (Fig. 3b) , as well as with the shorter construct DrABD 300 and N-GSTfused DrABD (data not shown). We collected 9749 segments from images of actin filaments decorated with the drebrin fragment. During the first step of sorting, segments were separated by the occupancy (see Materials and Methods and Appendix A) and Fig. 1 . Binding of the drebrin constructs to actin filaments. Binding affinity of drebrin constructs for F-actin was estimated by pelleting assays (see Materials and Methods). (a) Binding of the 1-300 drebrin construct to actin filaments (10 μM). The continuous line corresponds to the best data fit. A K d of the 1-300 drebrin construct for F-actin (0.17 ± 0.005 μM) was calculated based on two independent experiments. (b) Binding affinities of N-GST-fused DrABD constructs for F-actin (10 μM). Continuous lines correspond to the best data fit with K d values of 6.6 ± 0.4 and 7.6 ± 0.6 μM for DrABD and DrABD 300 , respectively. K d is an average value obtained in two independent experiments, as described in Materials and Methods. (c) Co-sedimentation of drADF with F-actin (Ac) (10 μM). (d) Control co-sedimentation of yeast cofilin (cof) with F-actin (10 μM) under the same conditions as in (c). Buffer composition: 5 mM Mops, pH 7.2, 0.2 mM CaCl 2 , 0.4 mM ethylene glycol bis(β-aminoethyl ether)N,N′ -tetraacetic acid, 0.2 mM ATP, 1 mM DTT, 50 mM KCl, and 2 mM MgCl 2 . Lanes 1-6, 10 μM F-actin co-sedimented with 1.25, 2.5, 5, 10, 15, and 25 μM concentrations of drADF; lanes 9-14, 10 μM F-actin co-sedimented with 1.25, 2.5, 5, 10, 15, and 25 μM concentrations of yeast cofilin; lanes 7 and 8, F-actin, supernatant and pellet, respectively. Based on the results of two independent experiments, the secondary structure composition of DrABD is estimated to contain 28% helix, 15% β-sheets, and 57% turns and random coil.
"naked" F-actin segments were reconstructed separately from occupied ones. Reconstruction of the naked F-actin (Fig. 3c) was similar to the reconstruction of pure F-actin from our previous studies. 17 Five modes of DrABD binding to actin filaments are shown in Fig. 3d -h. To estimate whether the observed additional mass in the reconstructions was consistent with the molecular weight of the drebrin construct, we used a portion of the globular CH domain of α-actinin (Protein Data Bank ID 1wku) that consists of 84 residues (∼ 9 kDa). This model protein fragment was filtered to ∼ 24-Å resolution, and its expected molecular volume was docked into the drebrin density in each map ( Fig. 3d-h, magenta mesh) . In the first mode (Fig. 3d) , drebrin bridges to two adjacent actin protomers and makes an extensive contact with SD1 and SD2. In the mode shown in Fig. 3e , drebrin is located in front of actin SD1. We also observed drebrin in a mode similar to the one shown in Fig. 3d , but in this mode, DrABD interacts with one protomer at a time (Fig. 3f) . We suggest that all three modes shown in Fig. 3d , e, and f are variations of a major DrABD binding site (∼ 40% of segments), which involves SD1 and SD2 of actin.
We found that ∼ 15% of the segments decorated with DrABD reflect a different type of attachment ( Fig. 3g and h ). In the binding mode shown in Fig. 3g , DrABD is attached to the sides of SD1 and SD2. In this case, the observed mass was larger than the mass corresponding to a globular protein fragment of 84 amino acids, which suggests that, in this mode, DrABD binds to filaments as an oligomer. Interestingly, in this mode, DrABD makes contact with SD4 of an actin protomer on the opposite strand (Fig. 3g, red arrow) . This contact is more prominent in the mode shown in Fig. 3h .
The same modes of binding as documented for DrABD were also observed for the 1-300 construct, despite its much higher affinity for F-actin (∼0.2 μM) (Figs. 1a and 3d ⁎ -h ⁎ ). It should be noted that the 1-300 construct may contain weak actin-interacting sites other than DrABD, which would explain its higher affinity for the actin filaments. However, the results of EM reconstruction suggest that DrABD contains the strongest binding site within the 1-300 drebrin fragment and probably competes with weaker bound structural elements for interaction with actin when the 1-300 fragment is added in excess. Based on our EM results and previous in vivo studies, the DrABD construct was chosen for mapping the drebrin binding site on F-actin.
DrABD bridges two actin protomers
To probe the DrABD/F-actin binding interface via cross-linking reactions, we employed the modification of DrABD with 2-iminothiolane (Traut's reagent). This reagent was used to introduce sulfhydryl (-SH) groups on the surface of the fragment. Potentially, all five lysines (K238, K248, K252, K270, and K271) and the N-terminal amino group can be modified with 2-iminothiolane. Additionally, DrABD contains native cysteine 308 within its C-terminal unstructured extension (residues 301-317). Considering the relatively low affinity of DrABD to actin, we attached first the cross-linking reagents to F-actin, as was done earlier for the mapping of the actin-thymosin β4 complex. 18 Cross-linking experiments revealed that DrABD modified with Traut's reagent can be covalently attached to MTS1 [1,1-methanediyl bis (methanethiosulfonate)]-pre-modified F-actin, yielding two protein populations: actin-DrABD heterodimer and species that, according to their molecular weight, correspond to a complex of two actin protomers and one DrABD molecule (Fig. 4a) . A control experiment was carried out using MTS1-premodified F-actin and intact DrABD construct with no modifications. A significant amount of actinDrABD heterodimer was detected by SDS-PAGE under nonreducing conditions, indicating that native C308 on DrABD is involved in the cross-linking (Fig. 4b ).
C-terminal region of DrABD (residues 301-317) cross-links to C374 on actin
Our experiments revealed that DrABD can be efficiently cross-linked to both skeletal muscle (α-) and yeast wild-type (WT) (cytoplasmic) F-actin premodified with MTS1. The similar cross-linking yield (∼ 60%) obtained for both actins may indicate that the DrABD-actin interaction is not isoform specific. C-terminal cysteine 374 is the most reactive cysteine on actin and is expected to be efficiently modified with MTS1 reagents. 19 However, to confirm that the cross-linking on actin indeed involves C374, we used a yeast actin mutant with this residue substituted to alanine (C374A). No cross-linking was detected in the case of C374A actin mutant, which indicates that native C308 of drebrin locates within 5.4 Å from C-terminal cysteine 374 on actin (Fig. 4b) .
MS analysis of the purified complex of 2-iminothiolane-modified DrABD attached simultaneously to two actin protomers revealed that disulfide (MTS1) cross-linking between native C308 on DrABD and C10 on actin may also occur (Appendix B). However, the fact that unmodified DrABD can be efficiently cross-linked to WT yeast actin, which lacks C10, suggests that this type of attachment reflects a minor mode of DrABD-actin binding. The N-terminal part (233-271) of DrABD can be cross-linked to SD1 and SD2 of two adjacent actin protomers Site-directed mutagenesis was employed to locate the N-terminal part of DrABD (sequence 233-271) on actin filaments. Based on the results obtained with 2-iminothiolane-modified DrABD (Fig. 5a ), all five lysines (K238, K248, K252, K270, and K271) and the N-terminal glycine were potential candidates for cross-linking to the second actin protomer. To identify the residues on DrABD that are in close proximity actin, we created five mutants with single lysine-to-cysteine replacements in the construct DrABD 300 . These mutants did not impair the complex formation of DrABD 300 with F-actin (see Materials and Methods). The fact that DrABD bridges two actin protomers, making contacts with their C-terminal segments, called for probing the DrABD interaction with actin SD2. Actin mutants D51C/C374S and S60C/C374A were employed for such mapping. Mutant A144C/C374A was chosen to test for the binding of DrABD to the hydrophobic cleft between SD1 and SD3 of actin, which is known to interact with several actin-binding proteins (ABPs). All yeast actin mutants employed in this study show normal polymerization properties. 20, 21 We used a series of bis(methanethiosulfonate) (MTS) reagents as molecular rulers to estimate the distances between single reactive cysteines on actin and on DrABD mutants. 21 Experiments with skeletal F-actin pre-modified with MTS1 (5.4 Å) revealed that K238C is the one cross-linked most efficiently to C374 on actin among the five DrABD 300 mutants (Fig. 5a) . The cross-linking yields for three DrABD mutants, K238C, K248C, and K252C, and the MTS8 [3,6-dioxaoctane-1,8-diyl bis(methanethiosulfonate)]-pre-modified F-actin were very similar (27%-29%). These results suggest that lysines 238, 248, and 252 are in close enough proximity to C374 of actin (∼ 12 Å) to be involved in the formation of a trimer consisting of 2-iminothiolane-modified DrABD attached simultaneously to two actin protomers (Fig. 4a) . The low cross-linking efficiency documented for mutants K270C and K271C and actin pre-modified with the MTS reagents of different lengths precludes their proximity to C374 on actin (Fig. 5a) .
The experiments with MTS-modified yeast actin D51C/C374S revealed that all five DrABD 300 mutants could be linked very efficiently to actin with reagents of length ranging from ∼ 12.1 Å (MTS8) to 19 Å [MTS17; 3,6,9,12,15-pentaoxaheptadecane-1,17-diyl bis(methanethiosulfonate)] (Fig.  5b) . These data indicate that the N-terminal part of DrABD is centered on SD2 of actin. However, in the case of MTS1-modified D51C/C374S actin, the cross-linking efficiency of the introduced cysteine residues decreases with increasing distance from the N-terminus of the DrABD construct (Fig. 5b) . The fact that all five DrABD 300 mutants can be crosslinked efficiently to residue 51 on actin may indicate that the construct can adopt a folded conformation upon binding to F-actin.
No cross-linking was detected with all five DrABD 300 mutants and yeast actin S60C/C374S, with the reactive cysteine in SD2 facing the nucleotide binding cleft, and yeast actin A144C/ C374A, containing a reactive cysteine in the hydrophobic cleft (SD3) of actin (data not shown).
Zero-length cross-linking of DrABD to SD1 of actin
Our experiments showed that DrABD can be efficiently cross-linked to F-actin using the zerolength cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) ( Fig. 6a ; Appendix C). Bands corresponding to actin, DrABD, and actinDrABD heterodimer were excised from the SDS-PAGE gel and subjected to in-gel trypsin digest to The fragments were deconvoluted to a zero-charge spectrum and matched with theoretical masses predicted for the three cross-linking sites on the actin peptide (E99, E100, and E107) and the single cross-linking site on drebrin (the N-terminus) to fully assign the spectrum. The data were first filtered using a maximum error of ± 100 ppm to ensure high quality of the matches. In a second filtering step, the average and standard deviation of the errors were calculated and one standard deviation from the average (27 ± 37 ppm) was used as a filter. The identified fragments were then matched with the raw spectrum to increase the confidence by using the multiple charge states of each fragment. Fiftyseven fragments were found with unique interpretations (24 had two or more charge states), 11 fragments matched to sequences occurring more than once in the peptide sequence, and 16 ions could be matched to more than one fragment (within experimental error). To assign the latter to single fragments, we evaluated the number of fragmentations necessary to form the fragment and the presence of supporting ions from related fragments. The massto-charge ratio (m/z) and the charge of each fragment were manually verified from the raw spectrum. The interpretation of the data fits with a cleavage of 24 bonds, out of 26. Twenty-one fragments support a cross-link at E99 or E100 located in SD1 (major population) of actin, while 6 fragments (i.e., a minor population) support a cross-link at E107 ( Fig. 6b ; Appendix C).
Discussion
In order to identify contact sites between actin and drebrin, we employed site-directed mutagenesis, EM reconstruction, chemical cross-linking, and MS analysis. Using a set of thiol-specific reagents of different lengths as molecular rulers, we were able to assign the distances between selected residues on 4+ peak in MS spectra, corresponding to cross-linked peptides, was fragmented using electrospray ionization MS/MS (Waters Synapt QTOF mass spectrometer). Some of the identified fragments are indicated in the figure. The first digit indicates the peptide from which the fragment originates (1 = actin, 2 = drebrin), the letter refers to the ion series, and the last digit represents the ion number. Hyphenated labels indicate cross-linked fragments, with the left fragment originating from actin and the right one from drebrin. "M" represents intact drebrin peptide. The inset shows a schematic representation of the crosslinked peptides. In the scheme, the cross-linked residues are connected with a continuous line (major site); a minor crosslinking site on actin peptide is marked by the asterisk. (b) Internal ions of the cross-linked peptides support the attachment of N-terminal Gly of DrABD to E99/E100 (major population) and E107 (minor cross-link) on actin.
actin and DrABD in the range of 0 to ∼ 19 Å. The results of EM reconstruction revealed polymorphism in DrABD binding to actin filaments and suggested the existence of at least two binding sites for DrABD.
The contents of helical and β-structures estimated for DrABD using CD spectroscopy were 28% and 15%, respectively. However, secondary structure prediction algorithms did not predict any β-structures in DrABD (Fig. 2) . Our current crystallization attempts, if successful, would resolve this contradiction. The level of random coil and turns estimated by CD (57%) was in good agreement with the predictions made by Jpred 3 (∼ 50%), which suggests proper folding. 22 The affinity of DrABD for F-actin determined by pelleting experiments (K d of ∼ 6.6-7.6 μM) was relatively low compared with the affinity reported for the full-length drebrin (0.12 μM). 6 Our observation that drebrin construct 1-300 has a significantly higher affinity for F-actin compared with DrABD (∼0.2 μM; Fig. 1 ) raises the possibility that regions other than DrABD may also contribute to the actin binding. We hypothesize that either the ADF-homology domain or the linker region (residues 143-232) contributes to the stronger binding of drebrin 1-300 to F-actin than that of DrABD. Our EM reconstruction results (see below) suggest that DrABD is the strongest actin binding region within the 1-300 drebrin fragment, and identification of weaker binding sites is a subject for a separate study.
The fact that the shorter construct of DrABD 300 (with deletion of 17 C-terminal amino acids) has approximately the same affinity to F-actin as the longer construct (sequence 233-317) indicates that the unstructured region 301-317 does not contribute significantly to the DrABD/F-actin interaction (Fig. 1b) .
Chemical cross-linking for mapping the protein binding interface
Several DrABD and actin mutants containing single reactive cysteines were reacted with a series of thiol-specific bifunctional MTS reagents to probe the actin-DrABD binding interface. In general, the cross-linking efficiency depends on the reactivity and accessibility of the targeted residues, stability of the cross-linking reagents in solution, and experimental conditions (pH, temperature, reaction time).
The results of our cross-linking and pelleting experiments suggest that DrABD bridges two adjacent actin protomers. However, these data are insufficient to determine the orientation of DrABD on actin filaments. Based on our results summarized in Fig. 7 , we discuss the interaction of DrABD with protomers 1 and 2 in the actin filament. 23 
Cross-linking of DrABD to actin SD1 (protomer 1)
After thrombin cleavage, the recombinant DrABD constructs contain a G-S N-terminal extension. MS analysis identified the N-terminal glycine on DrABD as a residue cross-linked to Factin with a zero-length cross-linking reagent (EDC) (Appendix C). On actin, three residues in SD1 were shown to be involved in EDC crosslinking with DrABD: E99 and/or E100 (major population) and E107 (minor population) (Fig. 6) . Although a distinction between cross-linking to E99 and E100 is not possible from the fragmentation pattern of the cross-linked peptides, we conclude based on the abundance of the internal fragments of the cross-linked peptides that DrABD cross-linking to E107 of actin represents a minor population. The analysis performed using GETAREA 1.0 software showed a significant decrease in solvent accessibility for actin residue E107 compared with E99 and 100. Based on that, we cannot rule out the possibility that the Nterminus of DrABD is flexible and locates in close proximity to all three residues (E100, E99, and E107) but its coupling to E107 is restricted by the accessibility of that residue. It is also conceivable that minor cross-linking to E107 of actin may reflect an alternative mode of DrABD binding or result from local damage to actin over the course of the reaction. Despite the high level of flexibility of DrABD in solution (our unpublished NMR data) and the predicted disordered state of its N-terminal region, only one cross-linked peptide was identified in the sample containing the DrABD-actin heterodimer, which indicates a specific DrABD interaction with the 99-107 actin region.
Cross-linking experiments employing skeletal α-actin pre-modified with MTS reagents and DrABD mutants containing single cysteine substitutions revealed that the N-terminal part of DrABD makes contact with the C-terminus of actin. Based on the highest cross-linking efficiency of the K238C mutant to MTS1-modified actin, we conclude that residue 238 of DrABD locates within ∼ 5.4 Å from C374 of actin (Fig. 5a) . The fact that longer-spanning reagents [MTS8 (12.1 Å) and MTS17 (19 Å)] crosslink the same K238C mutant to actin at lower efficiency may indicate that, in the extended conformation, these reagents do not fit well into the space between the two cysteine residues in the DrABD-actin complex, while the "gauche" conformations of the reagents may not have the appropriate geometry for bridging residues 374 and 238. Similar amounts of actin-DrABD heterodimer were obtained in the presence of mutants K238C, K248C, and K252C with MTS8, which indicates that these three residues are within ∼12 Å from the C-terminus of actin. Low cross-linking efficiency between C374 of actin and DrABD mutants C270 and C271 observed with the MTS reagents of different lengths indicates that those residues are distant from the C-terminus of actin (Fig. 5a ).
Cross-linking of DrABD to actin SD1 and SD2 (protomer 2)
Experiments with yeast actin mutant D51C/ C374S containing a single reactive cysteine in SD2 revealed that DrABD is close to this actin region. Residues 238, 248, 252, 270, and 271 on DrABD can all be efficiently attached to residue 51 on actin with MTS reagents of various lengths (5.4-19 Å) (Fig. 5b) . The efficiency of these reactions with MTS1 and MTS8 is slightly higher (by ∼ 8%) for the DrABD mutant K238C (Fig. 5b) . According to secondary structure predictions, lysines 248 and 252 of DrABD are located on a helix, and lower cross-linking efficiency for these mutants, compared with K238C, may indicate decreased solvent accessibility of these two residues. Our results indicate that all five lysines on DrABD are located within ∼ 12 Å or even closer (5.4 Å in the case of K238) residue 51 on actin.
Our cross-linking experiments also revealed that the C-terminal region of DrABD interacts with actin SD1 and that native cysteine 308 of drebrin locates within 5.4 Å from C374 on actin (Fig. 4b) . Minor cross-linking between C10 on actin and C308 on DrABD may reflect the flexibility of the C-terminal region of the DrABD construct, but it could also indicate an alternative binding mode (Appendix B).
EM reconstruction of F-actin decorated with DrABD is consistent with cross-linking results
We used a single-particle approach for the EM reconstruction of F-actin decorated with DrABD. 25 This method allows for sorting relatively short filament segments (∼ 400 Å long) by occupancy and the mode of drebrin binding to F-actin.
In four modes of binding (Fig. 3d-f and h ), the mass attributed to DrABD is consistent with a globular protein of ∼ 9 kDa attached to F-actin. The results of EM reconstruction together with the mapped location of residues 238, 248, 252, 270, and 271 on DrABD within ∼ 12 Å from residue 51 on actin lead to the conclusion that DrABD may adopt a globular conformation upon binding to actin. Our data suggest that in the modes presented in Fig. 3d-f and h, DrABD binds to F-actin predominantly as a monomer. However, we cannot exclude the possibility that in these four modes actin filaments are decorated by drebrin dimers/ oligomers, which are not observed due to low occupancy or disorder.
According to the EM reconstruction and in good agreement with our cross-linking results, DrABD makes extensive contacts with SD1 and SD2 of actin (Fig. 3) . In the modes presented in Fig. 3d and f, DrABD interacts with SD1 and SD2 that involves residues 51 and 99-100. In the mode shown in Fig. 3e , DrABD is located in front of SD1 of actin and the interface involves residues 99 and 100. In the minor binding mode presented in Fig. 3g, residues 51 , 99, 100, and 374 are in proximity to DrABD density. Also, in the mode presented in Fig. 3h , residues 51 and 374 are likely to be involved in the interaction with drebrin. Taken together, the EM data support the existence of two binding sites for DrABD on actin: a major site (modes shown in Fig. 3d-f , ∼ 40% segments) and a minor site (modes shown in Fig. 3g and h, ∼ 15% segments) where DrABD is shifted to the sides of SD1 and SD2 of actin and makes cross-strand contact with another actin protomer.
Our cross-linking experiments revealed that DrABD can be simultaneously attached to two adjacent actin protomers within one helical strand. According to our mapping, C374 residues on two adjacent protomers are involved in such double cross-linking, which appears to be inconsistent with the results of EM reconstruction (Figs. 4 and  5a ). However, it should be noted that the Cterminal extension of DrABD that cross-links to C374 of actin with MTS1 (Fig. 4b ) is predicted to be unstructured. Computational analysis performed using Insight II software revealed that the length of this C-terminal extension (amino acids 301-317, C α to C α ) spans between 4.7 and 26.7 Å. If this region is disordered, it would not be observed in the EM reconstructions. According to our MS analysis, a short N-terminal extension of DrABD makes contact with actin residues 99-100. We may speculate that DrABD consists of a helical core with the unstructured extensions docked to the SD1 regions of two adjacent actin protomers. An atomic-resolution structure of the DrABD-actin complex will be required to confirm this hypothesis.
Polymorphism of DrABD binding to actin: implications for competition with other ABPs
Along with drebrins, many other ABPs are involved in the regulation of the actin cytoskeleton in neuronal cells. At the molecular level, the interplay between ABPs in this system is poorly understood. Our results provide new structural insight into the reciprocal relationship between drebrin and other ABPs in the cell. Multiple binding modes to F-actin documented here for DrABD were reported earlier for other proteins, such as cofilin, 17 utrophin, 26 and tropomyosin. [27] [28] [29] [30] Thus, binding polymorphism is not an exception among actininteracting proteins and may play an important role in actin cytoskeletal regulation. Because construct 1-300 of drebrin binds to F-actin significantly tighter than DrABD yet shows the same modes of attachment to actin filaments (Figs. 1a and 3d ⁎ -h ⁎ ), the in vivo competition of DrABD with other ABPs would be functionally important.
This study revealed that the main DrABD binding site overlaps with the cofilin binding site on actin filaments, which would explain the competition between these two proteins. 11 Cofilin interacts with two actin protomers within the same helical strand: with an upper protomer at the hydrophobic cleft between SD1 and SD3 and with a lower protomer at the interface formed by SD1 and SD2. On the lower protomer, peptides 44-50, 28-29, and 88-101 appear to be involved in cofilin binding (F-binding site). 17, 31 On the upper protomer, the C-terminus of actin was shown to interact with cofilin. 21, 32 Thus, our mapping of DrABD sites on actin to regions proximal to residues D51, E99, E100 and the Cterminus indicates their overlap with the cofilin binding site.
It has been shown that drebrin overexpression causes displacement of α-actinin from dendritic spines, which is consistent with earlier in vitro observations. 8 An α-actinin was documented previously to interact with residues 86-117 and 350-375 on actin. 24 We have shown here that actin residues 99-107 and its C-terminus are near DrABD, explaining the previously observed competition between these two proteins. According to the in vitro studies, α-actinin can interact with both F-actin (through tandem CH domains) and NMDA receptors (through its central "rod" domain), anchoring actin filaments to the membrane. 33, 34 It is likely that the competition between drebrin and α-actinin affects the anchoring of actin filaments to the membrane and leads to the formation of the long protrusions observed upon drebrin overexpression. We may hypothesize that the observed polymorphism of DrABD binding to F-actin plays a role in the competition with spectrin family proteins, such as utrophin, which have multiple actin-binding modes. 26 Based on in vitro studies, it was suggested that drebrin and tropomyosin compete for the same actin binding site. In the absence of atomicresolution structures, the detailed mechanism of such competition remains unclear. Also, we cannot exclude that observed inhibition of drebrin binding occurs due to tropomyosin-induced conformational changes in F-actin. Our data suggest that the primary binding site of drebrin (Fig. 3d-f ) is inconsistent with simultaneous interaction of drebrin and myosin with F-actin because myosin binds to a similar interface on F-actin. 35 It is possible that the attachment of F-actin decorated by drebrin A to a glass surface coated with myosin-V occurs because of the shift of DrABD from its primary binding site to the minor one located on the side of the filament. 10 
Materials and Methods
Materials
MTS cross-linking reagents, MTS1, MTS8, and MTS17, were purchased from Toronto Research Chemicals (North York, Ontario, Canada). Millipore-filtered water and analytical-grade reagents were used in all experiments.
Molecular cloning and mutagenesis
Mouse (Mus musculus) brain RNA was purified using TRIzol reagent (Invitrogen). Reverse transcriptase-PCR was performed using SuperScript II (Invitrogen) to generate cDNA. Full-length drebrin A cDNA was cloned into pCR2.1-TOPO vector (Invitrogen) and used as a template for all drebrin constructs. DrABD was cloned into BamH1 and EcoR1 sites of pGEX-4T1 expression vector. DrABD 300 construct was created by introducing a stop codon after amino acid 300 (Val) in DrABD with a QuikChange kit (Stratagene). DrABD mutants K238C, K248C, K252C, K270C, and K271C that contain single lysine-to-cysteine replacements were created using the same kit. Drebrin construct 1-300 was obtained by introducing a stop codon after residue 300 in full-length drebrin A DNA subcloned into pGEX-4T1 expression vector. The primers for cloning and mutagenesis are given in Appendix D.
Protein expression and purification
Rabbit skeletal actin was purified from rabbit back muscle as described by Spudich and Watt. 36 Yeast actin was purified as described previously. 21 All drebrin ABD constructs were expressed in Rosetta cells. Cells were grown at 37°C until OD 600 =0.6-0.8, following the induction with 0.2 mM IPTG and 2 h of expression. Proteins were purified on glutathione-agarose according to the manufacturer's instructions and as detailed in Appendix A. The single cysteine mutations introduced into DrABD 300 construct did not impair its complex formation with F-actin (Fig. 8) . Consequently, we employed these mutants for mapping the drebrin interface on actin.
Actin polymerization and DrABD binding assays
Actin polymerization was monitored via light scattering with the PTI fluorometer set at 350 nm for the excitation and emission wavelengths. For pelleting experiments, polymerization of skeletal actin was induced by addition of 2.0 mM MgCl 2 and 100 mM KCl to the actin solution in 5 mM Tris, pH 8.0, 0.2 mM CaCl 2 , 0.2 mM ATP, and 5 mM β-mercaptoethanol. The samples were centrifuged at 312,500g for 30 min, at 4°C, in a Beckman TLA-100 rotor. Resulting pellets were solubilized in gel sample buffer and analyzed by SDS-PAGE. To quantify the amount of N-GST-fused DrABD co-sedimented with Factin, we loaded 0.4-3.6 μg of purified constructs on each gel as the standards. Gels were stained with Coomassie Blue. The intensities of the bands were estimated using Scion Image Software. Binding parameters (K d and B max ) were obtained by fitting the average data points in SigmaPlot 9.0. The resulting curves (Fig. 1) represent the best fit.
Actin modification and cross-linking
Immediately prior to the reaction, DTT was removed from G-actin samples over a Sephadex G-50 spin column equilibrated with thiol-free buffer containing 5 mM Mops, pH 7.2, 0.2 CaCl 2 , and 0.2 mM ATP. Drebrin ABD constructs were passed through a Zeba Desalt Spin Column (Pierce) equilibrated with the same buffer. Actin was polymerized in the presence of 2.0-3.0 mM MgCl 2 and 100 mM KCl. The reactions of F-actin modification with MTS were carried out at room temperature (1-10 min), at molar ratios of 0.95:1 of MTS/actin. Cross-linking reaction was started by mixing DrABD constructs with MTS-premodified F-actin. Aliquots were withdrawn from the reaction mixtures at selected time points, and free cysteine residues were blocked with N-ethyl maleimide. Crosslinking progress was monitored by SDS-PAGE under nonreducing conditions.
Circular dichroism
CD spectra of DrABD (0.5 mg/ml) in 5 mM Tris, pH 7.8, at 25°C were measured using a J-700 polarimeter (Jasco). Eight replicates of each spectrum were recorded using scanning speed of 20 nm/min, a data pitch of 0.5 nm, and a 4-s dwell time. Samples were measured in a quartz cuvette with a path length of 0.01 cm. CD spectra were deconvoluted using the Selcon3 algorithm. Secondary structure obtained from the CD spectra was compared with that calculated from the secondary structure prediction algorithm Jpred 3.
MS and data analysis
Actin, DrABD, and EDC cross-linked heterodimers were separated using PAGE. The gel bands were digested as described previously. 37 Actin, DrABD, and the trimer, consisting of 2-iminothiolane-modified DrABD attached to two adjacent protomers through MTS1, were separated using size-exclusion chromatography and digested insolution as described earlier 38 and detailed in the Appendix A. The peptides were first analyzed by matrixassisted laser desorption/ionization time-of-flight MS (Voyager DE-STR, Applied Biosystems, Framingham, MA), using the dried droplet method with dihydroxybenzoic acid as matrix, and then by MS/MS. The digests were desalted using microcolumns 39 packed with POROS R2 beads (Applied Biosystems) and eluted directly into glass capillaries (Proxeon Biosystems, Odense, Denmark) to be analyzed manually by MS/MS (Synapt HDMS, Manchester, UK).
Spectra for the unmodified samples were acquired first and then used as controls during the analysis of the crosslinked sample to determine unique peptide ions. In each analysis, a few relevant peptides were analyzed, each up to 25 min to ensure high spectrum quality. A small portion of the sample, cross-linked using MTS1, was incubated with 10 mM DTT for 1 h and analyzed by MS/MS to verify the disulfide nature of the cross-link. The cross-linked peptides were identified through manual interpretation of the raw spectra. To unambiguously assign the crosslinking site, we exhaustively assigned the spectra using inhouse written Perl scripts. First, theoretical masses were calculated from the cross-linked peptides, allowing for multiple cross-linking sites and modifications, and then the theoretical masses were matched with mass lists generated by processing the raw spectra with Mascot Distiller 2.0 using an error of 0.1 Da or 100 ppm. Assignments were verified in the raw spectra using isotope patterns and charge states. In some cases, more than one peptide assignment was possible within the experimental error, and then the number of cleavages and supporting ions (e.g., water loss or ammonium loss) was used to select the most likely candidate.
EM reconstruction
G-actin was purified using Superdex-200 column and frozen in liquid nitrogen. Before each experiment, an aliquot of actin was thawed at 4°C and clarified by centrifugation (100,000g, 1 h). Actin (5 μM) was polymerized in 10 mM Tris-HCl buffer, pH 7.8, containing 50 mM KCl, 1 mM MgCl 2 , 1 mM DTT, and 0.2 mM ATP, for 1.5-2 h. To obtain the filaments decorated with DrABD, we incubated 1-2 μM concentration of F-actin with 10-15 μM concentration of DrABD for 12-15 min at room temperature. An identical procedure was used for decorating actin with the 1-300 drebrin construct. Samples were applied to glow-discharged carbon-coated grids and stained with 2% uranyl acetate. The grids were examined in a Tecnai-12 electron microscope (FEI) under minimaldose conditions at an accelerating voltage of 80 keV and a nominal magnification of 30,000×. The SPIDER software package 40 was used for most image processing, but the EMAN package 41 was used to extract filament images from micrographs. A Nikon COOLPIX 8000 scanner was used to digitize micrographs at a raster of 4.16 Å per pixel. The IHRSR method 25 was used to generate an overall reconstruction from 9749 segments (each 416 Å long) of actin filaments decorated with DrABD (Fig. 3b) . Comparison of the overall reconstruction with the reconstruction of pure F-actin 17 revealed an additional mass attached to the front and side parts of SD1 and SD2 of actin protomers (see Appendix A for details). To evaluate whether that density was arising from a single drebrin molecule or was rather a superposition of multiple states of binding, we designed a set of models to decompose the additional density into several classes based on the possible location of drebrin on F-actin. The size of the additional mass, along with the quality of the actin portion of the map, was used as a guideline in the sorting process. The position of drebrin in its five modes of binding to F-actin relative to the additional density in the overall reconstruction is shown in Supplemental Fig. 1 . A detailed description of the sorting procedures has been published earlier. 26, 42 UCSF Chimera software 43 was used to fit the crystal structure of actin 44 into the experimental maps. Atomic coordinates from crystal structures were converted to density maps, and these were filtered to the resolution of the experimental map and docked manually.
